Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties

Biochemical and Biophysical Research Communications

Volumn 296, Issue 4, 2002, Pages 877-882

  Yamagishi, Sho ichi ^a   Inagaki, Yosuke ^a   Amano, Shinjiro ^a   Okamoto, Tamami ^a   Takeuchi, Masayoshi ^b   Makita, Zenji ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

Author keywords

AGE; Diabetic retinopathy; PEDF; Pericyte loss

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; DNA; LIGAND; MEMBRANE PROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CATTLE; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC NEPHROPATHY; DNA SYNTHESIS; DOWN REGULATION; DRUG MECHANISM; EYE PROTECTION; GENE EXPRESSION REGULATION; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RETINA; RETINA INJURY;

ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; DETERGENTS; DIABETIC RETINOPATHY; DNA; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE PROTEINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NERVE GROWTH FACTORS; PERICYTES; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RETINA; SERPINS; TRANSFECTION;

MAMMALIA;

EID: 0036382639     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00940-3     Document Type: Article

References (25)

1. J. Tombran-Tink, C.G. Chader, L.V. Johnson, PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity, Exp. Eye Res. 53 (1991) 411-414.
2. D.W. Dawson, O.V. Volpert, P. Gillis, S.E. Crawford, H.J. Xu, W. Benedict, N.P. Bouck, Pigment epithelium-derived factor: a potent inhibitor of angiogenesis, Science 285 (1999) 245-248.
3. E.J. Duh, H.S. Yang, I. Suzuma, M. Miyagi, E. Youngman, K. Mori, M. Katai, L. Yan, K. Suzuma, K. West, S. Davarya, P. Tong, P. Gehlbach, J. Pearlman, J.W. Crabb, L.P. Aiello, P.A. Campochiaro, D.J. Zack, Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth, Invest. Ophthalmol. Vis. Sci. 43 (2002) 821-829.
4. J. Spranger, M. Osterhoff, M. Reimann, M. Mohlig, M. Ristow, M.K. Francis, V. Cristofalo, H.P. Hammes, G. Smith, M. Boulton, F.H. Pfeiffer, Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease, Diabetes 50 (2002) 2641-2645.
5. F.A. L'Esperance, W.A. James, P.H. Judson, The eye and diabetes mellitus, in: H. Lifkin, D. Porte (Eds.), Ellenberg and Rifkin's Diabetes Mellitus, Theory and Practice, Elsevier, New York, NY, 1990, pp. 661-683.
6. L.J. Mandarino, Current hypotheses for the biochemical basis of diabetic retinopathy, Diabetes Care 15 (1992) 1892-1901.
7. R.N. Frank, On the pathogenesis of diabetic retinopathy. A 1990 updata, Ophthalmology 98 (1991) 586-593.
8. S. Yamagishi, C.C. Hsu, M. Taniguchi, S. Harada, Y. Yamamoto, K. Ohsawa, K. Kobayashi, H. Yamamoto, Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy, Biochem. Biophys. Res. Commun. 213 (1995) 681-687.
9. S. Yamagishi, S. Amano, Y. Inagaki, T. Okamoto, K. Koga, N. Sasaki, H. Yamamoto, M. Takeuchi, Z. Makita, Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes, Biochem. Biophys. Res. Commun. 290 (2002) 973-978.
10. F.R. Steele, G.J. Chader, L.V. Johnson, J. Tombran-Tink, Pigment epithelium-derived factor: neutrophic activity and identification as a member of the serine protease inhibitor gene family, Proc. Natl. Acad. Sci. USA 90 (1993) 1526-1530.
11. S. Yamagishi, H. Yonekura, Y. Yamamoto, K. Katsuno, F. Sato, I. Mita, H. Ooka, N. Satozawa, T. Kawakami, M. Nomura, H. Yamamoto, Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor, J. Biol. Chem. 272 (1997) 8723-8730.
12. A.F.S.A. Habeeb, Determination of free amino groups in proteins by trinitrobenzenesulfonic acid, Anal. Biochem. 14 (1966) 328-336.
13. S. Yamagishi, D. Edelstein, X.L. Du, Y. Kaneda, M. Guzmán, M. Brownlee, Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A, J. Biol. Chem. 276 (2001) 25096-25100.
14. S. Yamagishi, D. Edelstein, X.L. Du, M. Brownlee, Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction, Diabetes 50 (2001) 1491-1494.
15. S. Yamagishi, H. Fujimori, H. Yonekura, Y. Yamamoto, H. Yamamoto, Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells, Diabetologia 41 (1998) 1435-1441.
16. R.A. Reyes, G.L. Cockerell, Increased ratio of bcl-2/bax expression is associated with bovine leukemia virus-induced leukemo-genesis in cattle, Virology 242 (1998) 184-192.
17. S. Yamagishi, Y. Inagaki, T. Okamoto, S. Amano, K. Koga, M. Takeuchi, Z. Makita, Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells, J. Biol. Chem. 277 (2002) 20309-20315.
18. S. Yamagishi, T. Okamoto, S. Amano, Y. Inagaki, K. Koga, M. Koga, H. Choei, N. Sasaki, S. Kikuchi, M. Takeuchi, Z. Makita, Palmitate-induced apoptosis of microvascular endothelial cells and pericytes, Mol. Med. 8 (2002) 178-183.
19. M. Nomura, S. Yamagishi, S. Harada, Y. Hayashi, T. Yamashima, J. Yamashita, H. Yamamoto, Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes, J. Biol. Chem. 270 (1995) 28316-28324.
20. W. Cao, J. Tombran-Tink, W. Chen, D. Mrazek, R. Elias, J.F. McGimmis, Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death, J. Neurosci. Res. 57 (1999) 789-800.
21. G. Ermak, K.J. Davies, Calcium and oxidative stress: from cell signaling to cell death, Mol. Immunol. 38 (2002) 713-721.
22. S. Yamagishi, K. Kobayashi, H. Yamamoto, Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells, Biochem. Biophys. Res. Commun. 190 (1993) 418-425.
23. S. Yamagishi, C.C. Hsu, K. Kobayashi, H. Yamamoto, Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes, Biochem. Biophys. Res. Commun. 191 (1993) 840-846.
24. H. Vlassara, H. Fuh, T. Donnelly, M. Cybulsky, Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits, Mol. Med. 1 (1995) 447-456.
25. T. Kislinger, N. Tanji, T. Wendt, W. Qu, Y. Lu, L.J. Ferran Jr., A. Taguchi, K. Olson, L. Bucciarelli, M. Goova, M.A. Hofmann, G. Cataldegirmen, V. D' Agati, M. Pischetsrieder, D. Stern, A.M. Schmidt, Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice, Arterioscler. Thromb. Vasc. Biol. 21 (2001) 905-910.